Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides next revision
covid-19_vaccines:adverse_events:lymphadenopathy:axillary_adenopathy [2022/01/21 22:11]
robin created
covid-19_vaccines:adverse_events:lymphadenopathy:axillary_adenopathy [2022/01/21 22:11] (current)
robin [Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Axillary Adenopathy]
Line 39: Line 39:
 [[https://pubmed.ncbi.nlm.nih.gov/34655312/|COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA.]] [[https://pubmed.ncbi.nlm.nih.gov/34655312/|COVID-19 vaccine-induced unilateral axillary adenopathy: follow-up evaluation in the USA.]]
  
-[[https://pubmed.ncbi.nlm.nih.gov/33625299/|Adenopathy after COVID-19 vaccination.+[[https://pubmed.ncbi.nlm.nih.gov/33625299/|Adenopathy after COVID-19 vaccination]]
  
Back to top